Roles for Paraoxonase but not Ceruloplasmin in Peritoneal Washing Fluid in Differential Diagnosis of Gynecologic Pathologies |
Yildirim, Mustafa
(Department of Medical Oncology, Ministry of Health Batman Regional Govermant Hospital)
Demirpence, Ozlem (Department of Biochemistry, Ministry of Health Batman Regional Govermant Hospital) Kaya, Vildan (Department of Radiation Oncology, Suleyman Demirel University) Suren, Dinc (Department of Pathology, Antalya Education and Research Hospital) Karaca, Mehmet (Department of Obstetrics and Gynecology, Antalya Education and Research Hospital) Evliyaoglu, Osman (Department of Biochemistry, Ministry of Health Batman Regional Govermant Hospital) Yilmaz, Necat (Department of Biochemistry, Antalya Education and Research Hospital) Gunduz, Seyda (Department of Medical Oncology, Antalya Education and Research Hospital) |
1 | Ahn JM, Sung HJ, Yoon YH, et al (2013). Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol Cell Proteomics. |
2 | Akcay MN, Polat MF, Yilmaz I, Akcay G (2003). Serum paraoxonase levels in pancreatic cancer. Hepatogastroenterology, 50, 225-7. |
3 | Akcay MN, Polat MF, Yilmaz I, Akcay G (2003). Serum paraoxonase levels in gastric cancer. Hepatogastroenterology, 50, 273-5 |
4 | Anastasiadis P, Koutlaki N, Liberis V, et al (2011). The contribution of rapid intraoperative cytology in the evaluation of endometrial cancer spread. Ann Acad Med Singapore, 40, 80-3. |
5 | Arpaci A, Gormus U, Dalan B, Berkman S, Isbir T (2009). Investigation of PON1 192 and PON1 55 polymorphisms in Ovarian Cancer Patients in Turkish Population. In Vivo, 23, 421-4. |
6 | Bobin-Dubigeon C, Jaffre I, Joalland MP, et al (2012). Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence. Clin Biochem, 45, 1503-5. DOI |
7 | Camuzcuoglu H, Arioz DT, Toy H, et al (2009). Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol Oncol, 112, 481-5. DOI |
8 | Canales A, Sanchez-Muniz FJ (2003). Paraoxanase, something more than an enzyme? Med Clin, 121, 537-48. DOI |
9 | Delimaris I, Faviou E, Antonakos G, et al (2007). Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem, 40, 1129-34. DOI |
10 | Eckerson HW, Romson J, Wyte C, La Du BN (1983). The human serum paraoxonase polymorphism: identification of Phenotypes by their response to salts. Am J Hum Genet, 35, 214-27. |
11 | Elkiran ET, Mar N, Aygen B, et al (2007). Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer, 7, 48. DOI |
12 | Khersonsky O, Tawfik DS (2005). Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry, 44, 6371-82. DOI ScienceOn |
13 | Kokouva M, Koureas M, Dardiotis E, et al (2013). Relationship between the paraoxonase 1 (PON1) M55L and Q192R polymorphisms and lymphohaematopoietic cancers in a Greek agricultural population. Toxicology, 307, 12-6. DOI |
14 | Kosaka T, Yamaguchi M, Motomura T, Mizuno K (2005). Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay. Clin Chim Acta, 359, 156-62. DOI |
15 | Krzystek-Korpacka M, Boehm D, Matusiewicz M, et al (2008). Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromesconnection with inflammation. Clin Biochem, 41, 804-11. DOI |
16 | La Du BN, Piko JI, Eckerson HW, Vincent-Viry M, Siest G (1986). An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism. Ann Biol Clin, 44, 369-72. |
17 | La Du BN, Aviram M, Billecke S, et al (1999). On the physiological role(s) of the paraoxonasese. Chem Biol Interac, 119-120, 379-88. DOI ScienceOn |
18 | La Du BN, Billecke S, Hsu C, Haley RW, Broomfield CA (2001). Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affect-ing individual sensitivity to environmental chemicals. Drug Metab Dispos, 29, 566-9. |
19 | Macharia M, Hassan MS, Blackhurst D, Erasmus RT, Matsha TE (2012). The growing importance of PON1 in cardiovascular health: a review. J Cardiovasc Med (Hagerstown), 13, 443-53. DOI |
20 | Mathur V, John PJ, Soni I, Bhatnagar P (2008). Blood levels of organochlorine pesticide residues and risk of reproductive tract cancer among women from Jaipur, India. Adv Exp Med Biol, 617, 387-94. DOI |
21 | Ng CJ, Shih DM, Hama SY, et al (2005). The paraoxonase gene family and atherosclerosis. Free Radic Biol Med, 38, 153-63. DOI ScienceOn |
22 | Nowak M, Wielkoszynski T, Marek B, et al (2010). Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clin Exp Med, 10, 185-92. DOI |
23 | Ozyilkan O, Baltali E, Ozyilkan E, et al (1992). Ceruloplasmin level in women with breast disease. Preliminary results. Acta Oncol, 31, 843-6. DOI |
24 | Ray G, Batra S, Shukla NK, et al (2000). Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat, 59, 163-70. DOI ScienceOn |
25 | Sankaranarayanan R, Ferlay J (2006). Worldwide burd of gynaecological cancer; the size of the problem. Best Pract Res Clin Obstet Gynaecol, 20, 207-25. DOI ScienceOn |
26 | Sarkar M, Konar H, Raut DK (2012). Gynecological malignancies: epidemiological characteristics of the patients in a tertiary care hospital in India. Asian Pac J Cancer Prev, 13, 2997-3004. 과학기술학회마을 DOI |
27 | Sathiakumar N, MacLennan PA, Mandel J, Delzell E (2011). A review of epidemiologic studies of triazine herbicides and cancer. Crit Rev Toxicol, 41, 1-34. |
28 | Senra Varela A, Lopez Saez JJ, Quintela Senra D (1997). Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Lett, 121, 139-45. DOI |
29 | Sharifi S, Ducatman BS, Wang HH, Fraser JL (1999). Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases. Cancer, 87, 259-62. DOI |
30 | Selvaggi SM (2003). Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol, 28, 335-41. DOI |
31 | Shield P (2004). Peritoneal washing cytology. Cytopathology, 15, 131-41. DOI |
32 | Stevens VL, Rodriguez C, Talbot JT, et al (2008). Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort. Prostate, 68, 1336-40. DOI |
33 | Vaidya SM, Kamalakar PL (1998). Copper and ceruloplasmin levels in serum of women with breast cancer. Indian J Med Sci, 52, 184-7. |
34 | Yildirim M, Karakilinc H, Yildiz M, et al (2013). Non-hodgkin lymphoma and pesticide exposure in Turkey. Asian Pac J Cancer Prev, 14, 3461-3. 과학기술학회마을 DOI ScienceOn |
35 | Zhou ZJ, Zheng J, Wu QE, Xie F (2007). Carboxylic esterase and its associations with long-term effects of organophosphorus pesticides. Biomed Environ Sci, 20, 284-90. |
36 | Zuna RE, Behrens A (1996). Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J Natl Cancer Inst, 88, 980-7. DOI |
37 | Arumanayagam M, Wong FW, Rogers M, Swaminathan R (1993). Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma. Gynecol Obstet Invest, 35, 175-8. DOI ScienceOn |